Table of contents
Volume 95, Issue 7
Published online 3 October 2006 (767-952)
Clinical Studies |
Translational Therapeutics |
Molecular Diagnostics |
Epidemiology |
Letters to the Editor
Minireviews
Improving the outcome of patients with castration-resistant prostate cancer through rational drug development FREE
G Attard, D Sarker, A Reid, R Molife, C Parker and J S de Bono
Br J Cancer 95: 767-774; advance online publication, September 19, 2006; doi:10.1038/sj.bjc.6603223
ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia FREE
D Perrotti and P Neviani
Br J Cancer 95: 775-781; advance online publication, September 5, 2006; doi:10.1038/sj.bjc.6603317
Clinical Studies
Preoperative elevation of serum C – reactive protein is predictive for prognosis in myeloma bone disease after surgery FREE
A Zahlten-Hinguranage, H Goldschmidt, F W Cremer, G Egerer, T Moehler, D Witte, L Bernd, D Sabo and F Zeifang
Br J Cancer 95: 782-787; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603329
Vinorelbine plus trastuzumab combination as first-line therapy for HER 2-positive metastatic breast cancer patients: an international phase II trial FREE
A Chan, M Martin, M Untch, M G Gil, V Guillem-Porta, M Wojtukiewicz, P Kellokumpu-Lehtinen, H L Sommer, V Georgoulias, N Battelli, M Pawlicki, D Aubert, T Bourlard, J Gasmi, G Villanova and L Petruzelka on behalf of the Navelbine® Herceptin® Project
Br J Cancer 95: 788-793; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603351
Phase II and pharmacological study of oral paclitaxel (Paxoral) plus ciclosporin in anthracycline-pretreated metastatic breast cancer FREE
H H Helgason, C M F Kruijtzer, A D R Huitema, S G Marcus, W W ten Bokkel Huinink, M E Schot, J H Schornagel, J H Beijnen and J H M Schellens
Br J Cancer 95: 794-800; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603332
Cost-effectiveness of screening with contrast enhanced magnetic resonance imaging vs X-ray mammography of women at a high familial risk of breast cancer FREE
I Griebsch, J Brown, C Boggis, A Dixon, M Dixon, D Easton, R Eeles, D G Evans, F J Gilbert, J Hawnaur, P Kessar, S R Lakhani, S M Moss, A Nerurkar, A R Padhani, L J Pointon, J Potterton, D Thompson, L W Turnbull, L G Walker, R Warren and M O Leach for the UK Magnetic Resonance Imaging in Breast Screening (MARIBS) Study Group
Br J Cancer 95: 801-810; doi:10.1038/sj.bjc.6603356
Ten-year follow-up results of a randomised controlled study comparing level-I vs level-III axillary lymph node dissection for primary breast cancer FREE
H Kodama, Y Nio, C Iguchi and N Kan
Br J Cancer 95: 811-816; doi:10.1038/sj.bjc.6603364
Randomised study of adjuvant chemotherapy for completely resected p-stage I–IIIA non-small cell lung cancer FREE
K Nakagawa, H Tada, A Akashi, T Yasumitsu, K Iuchi, T Taki and K Kodama , The Osaka Lung Cancer Study Group, Japan
Br J Cancer 95: 817-821; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603336
Phase II study of SPI-77 (sterically stabilised liposomal cisplatin) in advanced non-small-cell lung cancer FREE
S C White, P Lorigan, G P Margison, J M Margison, F Martin, N Thatcher, H Anderson and M Ranson
Br J Cancer 95: 822-828; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603345
The multikinase inhibitor midostaurin (PKC412A) lacks activity in metastatic melanoma: a phase IIA clinical and biologic study FREE
M J Millward, C House, D Bowtell, L Webster, I N Olver, M Gore, M Copeman, K Lynch, A Yap, Y Wang, P S Cohen and J Zalcberg
Br J Cancer 95: 829-834; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603331
Do delays between diagnosis and surgery in resectable oesophageal cancer affect survival? a study based on West Midlands cancer registration data FREE
B S Kötz, S Croft and D R Ferry
Br J Cancer 95: 835-840; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603333
Will Rogers revisited: prospective observational study of survival of 3592 patients with colorectal cancer according to number of nodes examined by pathologists FREE
S George, J Primrose, R Talbot, J Smith, M Mullee, D Bailey, C du Boulay and H Jordan on behalf of the Wessex Colorectal Cancer Audit Working Group
Br J Cancer 95: 841-847; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603352
Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer FREE
J Harder, B Riecken, O Kummer, C Lohrmann, F Otto, H Usadel, M Geissler, O Opitz and H Hen
Br J Cancer 95: 848-852; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603334
Somatostatin receptor expression, tumour response, and quality of life in patients with advanced hepatocellular carcinoma treated with long-acting octreotide FREE
J Cebon Australasian Gastro-Intestinal Trials Group (AGITG) AG0001H Investigators
Br J Cancer 95: 853-861; advance online publication, September 5, 2006; doi:10.1038/sj.bjc.6603325
Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas FREE
K Ogawa, Y Yoshii, O Inoue, T Toita, A Saito, Y Kakinohana, G Adachi, S Iraha, W Tamaki, K Sugimoto, A Hyodo and S Murayama
Br J Cancer 95: 862-868; advance online publication, September 5, 2006; doi:10.1038/sj.bjc.6603342
Translational Therapeutics
Fatty acid synthase: a novel target for antiglioma therapy FREE
W Zhao, S Kridel, A Thorburn, M Kooshki, J Little, S Hebbar and M Robbins
Br J Cancer 95: 869-878; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603350
Antineoplastic effects of rosiglitazone and PPAR
transactivation in neuroblastoma cells FREE
I Cellai, S Benvenuti, P Luciani, A Galli, E Ceni, L Simi, S Baglioni, M Muratori, B Ottanelli, M Serio, C J Thiele and A Peri
Br J Cancer 95: 879-888; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603344
Expression of PPAR
in multistage carcinogenesis of the colorectum: implications of malignant cancer morphology FREE
O Takayama, H Yamamoto, B Damdinsuren, Y Sugita, C Y Ngan, X Xu, T Tsujino, I Takemasa, M Ikeda, M Sekimoto, N Matsuura and M Monden
Br J Cancer 95: 889-895; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603343
Efficient loading of dendritic cells following cryo and radiofrequency ablation in combination with immune modulation induces anti-tumour immunity FREE
M H M G M den Brok, R P M Sutmuller, S Nierkens, E J Bennink, C Frielink, L W J Toonen, O C Boerman, C G Figdor, T J M Ruers and G J Adema
Br J Cancer 95: 896-905; advance online publication, September 5, 2006; doi:10.1038/sj.bjc.6603341
Identification of gene polymorphisms of human DNA topoisomerase I in the National Cancer Institute panel of human tumour cell lines FREE
F Moisan, M Longy, J Robert and V Le Morvan
Br J Cancer 95: 906-913; advance online publication, September 19, 2006; doi:10.1038/sj.bjc.6603361
Molecular Diagnostics
Evaluation of models to predict BRCA germline mutations FREE
H H Kang, R Williams, J Leary, kConFab InvestigatorsC Ringland, J Kirk and R Ward
Br J Cancer 95: 914-920; doi:10.1038/sj.bjc.6603358
Heterogeneous nuclear ribonucleoprotein K is over expressed, aberrantly localised and is associated with poor prognosis in colorectal cancer FREE
B Carpenter, M McKay, S R Dundas, L C Lawrie, C Telfer and G I Murray
Br J Cancer 95: 921-927; advance online publication, September 5, 2006; doi:10.1038/sj.bjc.6603349
The impact of surgically induced ischaemia on protein levels in patients undergoing rectal cancer surgery FREE
G K Atkin, F M Daley, S Bourne, R Glynne-Jones, J M A Northover and G D Wilson
Br J Cancer 95: 928-933; doi:10.1038/sj.bjc.6603362
Epidemiology
Cancer risk among users of neuroleptic medication: a population-based cohort study FREE
S O Dalton, C Johansen, A H Poulsen, M Nørgaard, H T Sørensen, J K McLaughlin, P B Mortensen and S Friis
Br J Cancer 95: 934-939; advance online publication, August 22, 2006; doi:10.1038/sj.bjc.6603259
Impact of socio-economic deprivation on death rates after surgery for upper gastrointestinal tract cancer FREE
Y Leigh, V Seagroatt, M Goldacre and P McCulloch
Br J Cancer 95: 940-943; advance online publication, August 22, 2006; doi:10.1038/sj.bjc.6603315
Socioeconomic and geographic determinants of survival of patients with digestive cancer in France FREE
O Dejardin, L Remontet, A M Bouvier, A Danzon, B Trétarre, P Delafosse, F Molinié, N Maarouf, M Velten, E A Sauleau, N Bourdon-Raverdy, P Grosclaude, S Boutreux, G De Pouvourville and G Launoy
Br J Cancer 95: 944-949; advance online publication, September 12, 2006; doi:10.1038/sj.bjc.6603335
Letters to the Editor
High mortality from neo-adjuvant chemo-radiotherapy for rectal cancer needs to be evaluated against the alternative of adjuvant therapy FREE
S Papagrigoriadis
Br J Cancer 95: 950; doi:10.1038/sj.bjc.6603338
Reply: Adjuvant chemoradiotherapy is no alternative to intensified neoadjuvant chemoradiotherapy for local and systemic control in patients with locally advanced rectal cancer FREE
G Klautke and R Fietkau
Br J Cancer 95: 951-952; doi:10.1038/sj.bjc.6603339
The published online date indicates the date that the issue is published online and is the first official publication date of the issue. Each print issue of BJC is published one week after it has been published online.
